204 related articles for article (PubMed ID: 29292780)
1. Zinc-Modified Nanotransporter of Doxorubicin for Targeted Prostate Cancer Delivery.
Skalickova S; Loffelmann M; Gargulak M; Kepinska M; Docekalova M; Uhlirova D; Stankova M; Fernandez C; Milnerowicz H; Ruttkay-Nedecky B; Kizek R
Nanomaterials (Basel); 2017 Dec; 7(12):. PubMed ID: 29292780
[TBL] [Abstract][Full Text] [Related]
2. [Zinc-modified Nanotransporter for Target Drug Therapy of Breast Cancer].
Skaličková S; Gargulák M; Löffelmann M; Ruttkay-Nedecký B; Kepinská M; Parák T; Kizek R
Klin Onkol; 2017; 30(Supplementum1):174-176. PubMed ID: 28471199
[TBL] [Abstract][Full Text] [Related]
3. Zinc Modified Nanotransporter of Anticancer Drugs for Targeted Therapy: Biophysical Analysis.
Skalickova S; Docekalova M; Stankova M; Uhlirova D; Ruttkay-Nedecky B; Fernandez C; Kepinska M; Milnerowicz H; Kizek R
J Nanosci Nanotechnol; 2019 May; 19(5):2483-2488. PubMed ID: 30501743
[TBL] [Abstract][Full Text] [Related]
4. A Rapid Method for the Detection of Sarcosine Using SPIONs/Au/CS/SOX/NPs for Prostate Cancer Sensing.
Uhlirova D; Stankova M; Docekalova M; Hosnedlova B; Kepinska M; Ruttkay-Nedecky B; Ruzicka J; Fernandez C; Milnerowicz H; Kizek R
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30467297
[TBL] [Abstract][Full Text] [Related]
5. [Fullerene Doxorubicin Nanotransporter for Target Interaction with mutated gene BRCA2].
Skaličková S; Löfelmann M; Gargulák M; Dočekalová M; Ruttkay-Nedecký B; Suchý P; Kepinská M; Kizek R
Klin Onkol; 2017; 30(Supplementum1):177-179. PubMed ID: 28471200
[TBL] [Abstract][Full Text] [Related]
6. Design and Development of Graphene Oxide Nanoparticle/Chitosan Hybrids Showing pH-Sensitive Surface Charge-Reversible Ability for Efficient Intracellular Doxorubicin Delivery.
Zhao X; Wei Z; Zhao Z; Miao Y; Qiu Y; Yang W; Jia X; Liu Z; Hou H
ACS Appl Mater Interfaces; 2018 Feb; 10(7):6608-6617. PubMed ID: 29368916
[TBL] [Abstract][Full Text] [Related]
7. Chitosan-Raloxifene nanoparticle containing doxorubicin as a new double-effect targeting vehicle for breast cancer therapy.
Mohammadi Z; Samadi FY; Rahmani S; Mohammadi Z
Daru; 2020 Dec; 28(2):433-442. PubMed ID: 32656689
[TBL] [Abstract][Full Text] [Related]
8. Targeted doxorubicin delivery and release within breast cancer environment using PEGylated chitosan nanoparticles labeled with monoclonal antibodies.
Helmi O; Elshishiny F; Mamdouh W
Int J Biol Macromol; 2021 Aug; 184():325-338. PubMed ID: 34119547
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
[TBL] [Abstract][Full Text] [Related]
10. Development of novel biofunctionalized chitosan decorated nanocochleates as a cancer targeted drug delivery platform.
Bothiraja C; Rajput N; Poudel I; Rajalakshmi S; Panda B; Pawar A
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):447-461. PubMed ID: 29368543
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab.
Yousefpour P; Atyabi F; Vasheghani-Farahani E; Movahedi AA; Dinarvand R
Int J Nanomedicine; 2011; 6():1977-90. PubMed ID: 21976974
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-Modified Apoferritin Nanotransfer for Targeted Cytostatic Transport.
Čížek M; Gargulák M; Sehnal K; Uhlířová D; Staňková M; Dočekalová M; Ruttkay-Nedecký B; Zídková J; Kizek R
Klin Onkol; 2019; 32(3):197-200. PubMed ID: 31216851
[TBL] [Abstract][Full Text] [Related]
13. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
14. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
[TBL] [Abstract][Full Text] [Related]
15. Covalently coupling doxorubicin to polymeric nanoparticles as potential inhaler therapy:
Ak G
Pharm Dev Technol; 2021 Oct; 26(8):890-898. PubMed ID: 34256658
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of doxorubicin to breast cancer cells by magnetic LHRH chitosan bioconjugated nanoparticles.
Varshosaz J; Hassanzadeh F; Aliabadi HS; Khoraskani FR; Mirian M; Behdadfar B
Int J Biol Macromol; 2016 Dec; 93(Pt A):1192-1205. PubMed ID: 27693338
[TBL] [Abstract][Full Text] [Related]
17. Chlorin e6 decorated doxorubicin encapsulated chitosan nanoparticles for photo-controlled cancer drug delivery.
Bhatta A; Krishnamoorthy G; Marimuthu N; Dihingia A; Manna P; Biswal HT; Das M; Krishnamoorthy G
Int J Biol Macromol; 2019 Sep; 136():951-961. PubMed ID: 31226376
[TBL] [Abstract][Full Text] [Related]
18. Facile solvothermal synthesis of mesostructured Fe3O4/chitosan nanoparticles as delivery vehicles for pH-responsive drug delivery and magnetic resonance imaging contrast agents.
Zhao G; Wang J; Peng X; Li Y; Yuan X; Ma Y
Chem Asian J; 2014 Feb; 9(2):546-53. PubMed ID: 24259489
[TBL] [Abstract][Full Text] [Related]
19. Development of anti-HER2-targeted doxorubicin-core-shell chitosan nanoparticles for the treatment of human breast cancer.
Naruphontjirakul P; Viravaidya-Pasuwat K
Int J Nanomedicine; 2019; 14():4105-4121. PubMed ID: 31239670
[No Abstract] [Full Text] [Related]
20. Fabrication of an amperometric sarcosine biosensor based on sarcosine oxidase/chitosan/CuNPs/c-MWCNT/Au electrode for detection of prostate cancer.
Narwal V; Kumar P; Joon P; Pundir CS
Enzyme Microb Technol; 2018 Jun; 113():44-51. PubMed ID: 29602386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
